Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration.
about
The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic reviewManaging bevacizumab-induced intraocular inflammation.Batch-related sterile endophthalmitis following intravitreal injection of bevacizumab.Delayed onset panuveitis following intravitreal aflibercept injection.Acute sterile endophthalmitis following intravitreal bevacizumab: case series.Short-term outcomes of aflibercept for neovascular age-related macular degeneration in eyes previously treated with other vascular endothelial growth factor inhibitors.Endophthalmitis: state of the art.Current intravitreal pharmacologic therapies for diabetic macular edema.Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.Retinal vascular changes following intravitreal ranibizumab injections for neovascular AMD over a 1-year period.Sterile Inflammation after Intravitreal Injection of Aflibercept in a Korean Population.Drug-induced uveitisTachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration.Effect of subconjuctival and intraocular bevacizumab injection on angiogenic gene expression levels in a mouse model of corneal neovascularization.Endophthalmitis following intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration.Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.Endophthalmitis following intravitreal injections.Suspected bacterial endophthalmitis following intravitreal anti-VEGF injection: case series and literature review.Sterile endophthalmitis after intravitreal injections.Acute bacterial endophthalmitis after intravitreal bevacizumab injection: Case report and literature review.Vitreous inflammation associated with intravitreal anti-VEGF pharmacotherapy.Global reported endophthalmitis risk following intravitreal injections of anti-VEGF: a literature review and analysis.Aflibercept administration in neovascular age-related macular degeneration refractory to previous anti-vascular endothelial growth factor drugs: a critical review and new possible approaches to move forward.Retinal venular calibre dilatation after intravitreal ranibizumab treatment for neovascular age-related macular degeneration.Anterior uveitis after treatment of age-related macular degeneration with ranibizumab and bevacizumab: uncommon complication.Evaluating the safety of intracameral bevacizumab application using oxidative stress and apoptotic parameters in corneal tissue.Case of endophthalmitis following intravitreal injections of bevacizumab.Anti-vascular endothelial growth factor in age-related macular degeneration: puzzle or a silent beginning!Vitreous web after pars plana vitrectomy and bevacizumab with fluid-air exchange.Comment on: Rebound inflammation after an intravitreal injection in Vogt-Koyanagi-Harada syndrome
P2860
Q27013836-7E2F95FE-6D8B-4FC3-91E3-068920E9F23EQ30463399-B617DCCD-B08F-4A7B-BB19-B5DBA81B27B2Q33780704-41F7259C-3287-4CB7-A5EF-91216BA5C3EAQ33802440-2ED8F35D-EE1A-4519-8685-EF4F8AE28678Q34182273-B064BAC1-4EB7-4DC5-A122-1DED132F0E8EQ34253393-AFD9F41A-A33C-41EA-AF1E-6C483A2C0BFEQ34952098-58A03C8E-9E87-4389-86ED-3FEF9023F346Q35650268-D1013A0B-FA81-416E-A597-E9D0F4C5C55BQ35693314-450B46BD-F972-4DE1-AFB8-FEB890286DE7Q36093275-54CFCF1E-C924-4B4B-92E9-446BD01749A4Q36127283-C5BC7569-0252-45F5-8A6A-E37E96C6E24FQ36797491-41DC81DF-3A75-473A-B667-3D933E25DD78Q37406558-6E76F6AD-77F2-4550-8448-DE91A767C377Q37425259-28036776-3DAE-48E3-88AE-3A50FD6A8383Q37879167-102F34CD-C580-48C7-B2B2-8F3CEC5E53A4Q37910660-4CFCD516-3122-4B13-AA5C-8F5B2C21DDA1Q37952079-015CE976-C2ED-4EE4-92D2-119F7C7A2745Q38026388-C2C5C865-A338-4E9F-AE14-42328426EA0CQ38042910-02E70C26-8F21-48ED-BF4E-BA2AB870EC15Q38130492-A5C861FA-ECCE-4A72-BD1B-161B83838B7FQ38168825-30F3D1F6-AED1-4D5A-8CEB-4C1224DFEC68Q38497083-761B0F18-9A91-41AA-814A-FAF41E38B920Q38582381-4368EF60-8FF5-4D35-A65C-238CF7A96FF7Q39986921-C2DFF4ED-4A62-4439-B8F2-0EFC1D4CA3E3Q42018233-E17D6578-B43F-4572-B946-D0460EACF559Q42567095-D9F4D4C1-BB46-419A-9CBD-4B2043C2B2CCQ42581034-80D2D799-3568-4160-9F57-850770E599D8Q42881794-93AAD2C3-0610-495F-929A-2242323CAEE9Q46894081-02103058-3660-416F-B890-EDAC1BBFAC93Q58792640-F886396F-98BA-41C6-A9F2-F9C32A4FE5CD
P2860
Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Acute intraocular inflammation ...... -related macular degeneration.
@en
Acute intraocular inflammation ...... -related macular degeneration.
@nl
type
label
Acute intraocular inflammation ...... -related macular degeneration.
@en
Acute intraocular inflammation ...... -related macular degeneration.
@nl
prefLabel
Acute intraocular inflammation ...... -related macular degeneration.
@en
Acute intraocular inflammation ...... -related macular degeneration.
@nl
P2093
P1433
P1476
Acute intraocular inflammation ...... e-related macular degeneration
@en
P2093
C Alex Harper
Jagjit Gilhotra
Kira Michalova
Salmaan Qureshi
Sanjeewa S Wickremasinghe
Tien Y Wong
P304
P356
10.1016/J.OPHTHA.2008.05.007
P577
2008-07-31T00:00:00Z